BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30182212)

  • 21. Isoflurane activates AMP-activated protein kinase to inhibit proliferation, and promote apoptosis and autophagy in cervical carcinoma both
    Wei H; Sun T; Liu J; Wang X; Zhao G; Shi J; Chen Y
    J Recept Signal Transduct Res; 2021 Dec; 41(6):538-545. PubMed ID: 33043765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
    Liu X; Chen D; Liu J; Chu Z; Liu D
    Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the BRIP1 ameliorates chemosensitivity to cisplatin by inhibiting Rac1 GTPase activity in cervical carcinoma HeLa cells.
    Liu Y; Li H; Zhang R; Dang H; Sun P; Zou L; Zhang Y; Gao Y; Hu Y
    Gene; 2016 Mar; 578(1):85-91. PubMed ID: 26680099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway.
    Hakimee H; Hutamekalin P; Tanasawet S; Chonpathompikunlert P; Tipmanee V; Sukketsiri W
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3539-3545. PubMed ID: 31870092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism.
    Polat IH; Tarrado-Castellarnau M; Bharat R; Perarnau J; Benito A; Cortés R; Sabatier P; Cascante M
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function.
    Daneshmandi S; Cassel T; Higashi RM; Fan TW; Seth P
    Elife; 2021 Oct; 10():. PubMed ID: 34709178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.
    Wang Y; Wang B; Guerram M; Sun L; Shi W; Tian C; Zhu X; Jiang Z; Zhang L
    Oncotarget; 2015 Oct; 6(30):29497-512. PubMed ID: 26470595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of 6-phosphogluconate dehydrogenase generates CD8
    Daneshmandi S; Cassel T; Lin P; Higashi RM; Wulf GM; Boussiotis VA; Fan TW; Seth P
    Cell Rep; 2021 Mar; 34(10):108831. PubMed ID: 33691103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
    Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
    Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
    Shan C; Elf S; Ji Q; Kang HB; Zhou L; Hitosugi T; Jin L; Lin R; Zhang L; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
    Mol Cell; 2014 Aug; 55(4):552-65. PubMed ID: 25042803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HeLa human cervical cancer cell migration is inhibited by treatment with dibutyryl-cAMP.
    Lee JW; Lee J; Moon EY
    Anticancer Res; 2014 Jul; 34(7):3447-55. PubMed ID: 24982353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
    PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.
    Pan B; Liu C; Su J; Xia C
    Cell Commun Signal; 2024 Jun; 22(1):306. PubMed ID: 38831454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
    Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
    Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK.
    Zhang Y; Peng X; Zheng Q
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1074-1079. PubMed ID: 29777701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells.
    Xie Z; Wang F; Lin L; Duan S; Liu X; Li X; Li T; Xue M; Cheng Y; Ren H; Zhu Y
    Cancer Lett; 2020 Dec; 495():200-210. PubMed ID: 32931885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
    Tang Q; Wu J; Zheng F; Hann SS; Chen Y
    Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.